Pfizer Inc
NYSE: PFE
$24.80
-$1.22 (-4.7%)
Closing Price on November 15, 2024
PFE Articles
June 8, 2016: Markets opened higher for a third straight day Wednesday boosted by rising crude oil prices and a falling dollar. An premarket jump in shares of LendingClub helped out until the opening...
Published:
Last Updated:
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
Published:
Last Updated:
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Published:
Last Updated:
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
Published:
Last Updated:
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
However, one medical supply company stood out, as short sellers piled on Baxter International in the first two weeks of the month.
Published:
Last Updated:
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
Published:
Last Updated:
Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more than $5 billion.
Published:
Last Updated:
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
Published:
Last Updated:
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
As the markets reached all-time highs last month, the short sellers were in retreat, judging by the moves in the most heavily shorted stocks traded on the New York Stock Exchange.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer and SolarCity.
Published:
Last Updated:
These stocks should do well for years regardless of who the next president is. They all have incredible franchises, long and mature product silos and, importantly, very strong consumer brand...
Published:
Last Updated:
One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the position that Medivation found itself in.
Published:
Last Updated:
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
Published:
Last Updated: